Advertisement
Advertisement
U.S. Markets open in 4 hrs 25 mins
Advertisement
Advertisement
Advertisement
Advertisement

SomaLogic, Inc. (SLGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.5200-0.1600 (-3.42%)
At close: 04:00PM EDT
4.5200 0.00 (0.00%)
After hours: 04:12PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.6800
Open4.6000
Bid0.0000 x 4000
Ask0.0000 x 2900
Day's Range4.4000 - 4.6500
52 Week Range4.2000 - 14.7200
Volume2,396,358
Avg. Volume1,779,852
Market Cap818.902M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

    BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy trea

  • GlobeNewswire

    SomaLogic Announces June Conference Participation

    BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare ConferenceJune 8-9, 2022, in New York 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics ConferenceJoe Gogain, Director, Clinical R&D will present “Bigger data = better data. Detect 7,000 proteins at once with high throughput to optimize biomarker discover” durin

  • GlobeNewswire

    SomaLogic Reports First Quarter 2022 Financial Results

    Company to host conference call today at 4:30 p.m. ETBOULDER, Colo., May 12, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today reported financial results for the quarter ended March 31, 2022. “Our successful first quarter has kickstarted another exciting year for SomaLogic as we continue to apply the power of the human proteome to improve health and disease management,” said Roy Smythe, M.D., SomaLogic’s Chief Executive Officer. “We have already re

Advertisement
Advertisement